Atlas Trials

Study Comparing Two Doses of MG01CI and Placebo in Adults With Predominantly Inattentive Attention Deficit Hyperactivity Disorder

Clinical trial NCT01685281 · COMPLETED

Trial details

NCT number
NCT01685281
Sponsor
Alcobra Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
ADHD Predominantly Inattentive Type
Start date
2013-08-01
Primary completion
2013-12-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.